These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 8799968

  • 1. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?
    Nicoletti F, Bruno V, Copani A, Casabona G, Knöpfel T.
    Trends Neurosci; 1996 Jul; 19(7):267-71. PubMed ID: 8799968
    [Abstract] [Full Text] [Related]

  • 2. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
    Bruno V, Battaglia G, Copani A, D'Onofrio M, Di Iorio P, De Blasi A, Melchiorri D, Flor PJ, Nicoletti F.
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1013-33. PubMed ID: 11524608
    [Abstract] [Full Text] [Related]

  • 3. [Metabotropic glutamate receptors: new molecular targets in the treatment of neurological and psychiatric diseases].
    Luján-Miras R.
    Rev Neurol; 2001 Sep; 40(1):43-53. PubMed ID: 15696426
    [Abstract] [Full Text] [Related]

  • 4. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.
    Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, Schoepp DD.
    Nat Rev Drug Discov; 2005 Feb; 4(2):131-44. PubMed ID: 15665858
    [Abstract] [Full Text] [Related]

  • 5. The distinct role of mGlu1 receptors in post-ischemic neuronal death.
    Pellegrini-Giampietro DE.
    Trends Pharmacol Sci; 2003 Sep; 24(9):461-70. PubMed ID: 12967771
    [Abstract] [Full Text] [Related]

  • 6. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.
    Schoepp DD.
    J Pharmacol Exp Ther; 2001 Oct; 299(1):12-20. PubMed ID: 11561058
    [Abstract] [Full Text] [Related]

  • 7. Metabotropic glutamate receptors in the thalamocortical network: strategic targets for the treatment of absence epilepsy.
    Ngomba RT, Santolini I, Salt TE, Ferraguti F, Battaglia G, Nicoletti F, van Luijtelaar G.
    Epilepsia; 2011 Jul; 52(7):1211-22. PubMed ID: 21569017
    [Abstract] [Full Text] [Related]

  • 8. Group II metabotropic glutamate receptors reduce excitatory but not inhibitory neurotransmission in rat barrel cortex in vivo.
    Cahusac PM, Wan H.
    Neuroscience; 2007 Apr 25; 146(1):202-12. PubMed ID: 17346894
    [Abstract] [Full Text] [Related]

  • 9. Do glutamatergic agents represent a new class of antidepressant drugs? Part 1.
    Sanacora G.
    J Clin Psychiatry; 2009 Oct 25; 70(10):1473-5. PubMed ID: 19906350
    [No Abstract] [Full Text] [Related]

  • 10. Effect of chronic gestational treatment with the adenosine A1 receptor agonist R-phenylisopropyladenosine on metabotropic glutamate receptors/phospholipase C pathway in maternal and fetal brain.
    León DA, Albasanz JL, Castillo CA, Iglesias I, Martín M.
    J Neurosci Res; 2008 Nov 15; 86(15):3295-305. PubMed ID: 18615645
    [Abstract] [Full Text] [Related]

  • 11. Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders.
    Spooren W, Ballard T, Gasparini F, Amalric M, Mutel V, Schreiber R.
    Behav Pharmacol; 2003 Jul 15; 14(4):257-77. PubMed ID: 12838033
    [Abstract] [Full Text] [Related]

  • 12. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN.
    Brain Res; 2008 Mar 10; 1198():44-54. PubMed ID: 18261716
    [Abstract] [Full Text] [Related]

  • 13. Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia.
    Chaki S.
    Eur J Pharmacol; 2010 Aug 10; 639(1-3):59-66. PubMed ID: 20371240
    [Abstract] [Full Text] [Related]

  • 14. Activation of group II mGlu receptors inhibits voltage-gated Ca2+ currents in myenteric neurons.
    Chen WP, Kirchgessner AL.
    Am J Physiol Gastrointest Liver Physiol; 2002 Dec 10; 283(6):G1282-9. PubMed ID: 12388194
    [Abstract] [Full Text] [Related]

  • 15. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues.
    Julio-Pieper M, Flor PJ, Dinan TG, Cryan JF.
    Pharmacol Rev; 2011 Mar 10; 63(1):35-58. PubMed ID: 21228260
    [Abstract] [Full Text] [Related]

  • 16. mGlu3 receptor and astrocytes: partners in neuroprotection.
    Durand D, Carniglia L, Caruso C, Lasaga M.
    Neuropharmacology; 2013 Mar 10; 66():1-11. PubMed ID: 22564439
    [Abstract] [Full Text] [Related]

  • 17. Distinct roles of group I mGlu receptors in striatal function.
    Bonsi P, Platania P, Martella G, Madeo G, Vita D, Tassone A, Bernardi G, Pisani A.
    Neuropharmacology; 2008 Sep 10; 55(4):392-5. PubMed ID: 18602651
    [Abstract] [Full Text] [Related]

  • 18. Metabotropic glutamate receptors and the control of chronic pain.
    Chiechio S, Nicoletti F.
    Curr Opin Pharmacol; 2012 Feb 10; 12(1):28-34. PubMed ID: 22040745
    [Abstract] [Full Text] [Related]

  • 19. Metabotropic glutamate receptor 7: at the interface of cognition and emotion.
    O'Connor RM, Finger BC, Flor PJ, Cryan JF.
    Eur J Pharmacol; 2010 Aug 10; 639(1-3):123-31. PubMed ID: 20371242
    [Abstract] [Full Text] [Related]

  • 20. Metabotropic glutamate receptors: new targets for the control of tumor growth?
    Nicoletti F, Arcella A, Iacovelli L, Battaglia G, Giangaspero F, Melchiorri D.
    Trends Pharmacol Sci; 2007 May 10; 28(5):206-13. PubMed ID: 17433452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.